Home > Pressrelease > U.S. Intrauterine Devices Market size to exceed $3bn by 2030

U.S. Intrauterine Devices Market size to exceed $3bn by 2030

  • Published Date: July 5, 2022

U.S. Intrauterine Devices Market size is set to exceed USD 3 billion by 2030, according to a new research report by Global Market Insights Inc.

The increasing prevalence of unintended pregnancy & harmful side effects associated with other contraceptive methods comprising oral pills has augmented the adoption of intrauterine devices. Furthermore, variables such as facilitative initiatives by the government and private organizations to promote awareness regarding women’s health, family planning, and modern contraceptive methods are estimated to serve as a considerable impact rendering factor for market growth.

High number of unintended pregnancies will fuel the U.S. intrauterine devices market progression

Increasing number of unintended pregnancies and the surged awareness regarding family planning techniques will foster the market trends. The public spending related to unintended pregnancies is substantial and increases the economic burden on the healthcare system. These pregnancies are concerned with multiple negative health as well as financial consequences. Further, the increased awareness and adoption of family planning are expected to drive the use of contraception in reducing pregnancy-related health concerns among women as well as infants. In order to reduce the occurrence of unintended pregnancies, the government authorities & public organizations are also promoting the implementation and adoption of contraceptives comprising intrauterine devices.

Browse key industry insights spread across 207 pages with 281 market data tables & 14 figures & charts from the report, U.S. Intrauterine Devices Market Size By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), Industry Analysis Report, Zonal Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030in detail along with the table of contents:


Several advantages offered by copper intrauterine devices will propel the market landscape

Copper IUD segment was valued at around USD 224 million in 2021. This is attributed to the several advantages delivered in the prevention of unintended pregnancy efficiently. These devices can stay in place for up to 5-10 years and can simply be removed sooner, if required. It continually releases a small amount of copper into the uterus and can also be used for emergency contraception instead of the emergency contraceptive pill.

Furthermore, as per the research data, copper is around 99% effective at preventing pregnancy, boosting the segment revenue. Its key advantage is that it highly reduces the risk of unwanted pregnancy without the use of hormones that have been linked to several symptoms.

Increasing awareness regarding intrauterine devices among 30-34 age group in the U.S. will boost the U.S. intrauterine devices market forecasts

The 30-34 age group segment segment surpassed USD 292 million in 2021. This is owing to the rising number of unintended pregnancies and abortion rates among women aged between 30-34 years. The increasing abortion rates in the U.S. are highlighting the significant requirement for intrauterine devices among adult women. Additionally, factors such as progressive implementations of reproductive health education initiatives to promote awareness related to effective contraception methods have been observed to influence women’s choices, causing a rising inclination towards planned and delayed pregnancy.

Growing awareness among women regarding various IUD applications in Northeast zone will spur the U.S. intrauterine devices market statistics

Northeast zone crossed USD 216 million in 2021. This is due to the rising awareness regarding intrauterine devices, an upsurge in the demand for hormonal intrauterine devices, and favourable government initiatives among others. The adoption of novel strategies by the government to promote access to intrauterine devices and prevention of unwanted abortions & pregnancies is expected to amplify the industry revenue. Hence, the demand for intrauterine devices is highly augmenting in the Northeast owing to their convenience.

The Northeast is one of the leading nations in terms of women health initiatives and the government organization comprising Atrium Health Women's Care Northeast has employed several guidelines to bolster women health that include awareness regarding effective contraceptive methods.

Companies are focusing on strategies and launch of innovative products to expand customer base

Some of the major market players operating in the U.S. intrauterine devices market are Bayer AG, CooperSurgical Inc. (CooperCompanies) and Allergan (AbbVie Inc.). These industry players are focusing on novel product launches and strategic collaborations to progress in the market.

For instance, in August 2021, Bayer AG announced the U.S. Food and Drug Administration (U.S. FDA) approval for an extension of Intrauterine Device (IUD) Mirena (levonorgestrel-releasing intrauterine system) 52 mg for up to 7 years of pregnancy prevention. This approval helped the company to strengthen its product pipeline related to IUDs, thereby offering competitive advantage in the market. 

Authors: Sumant Ugalmugle, Rupali Swain

Explore More on Related Topics: